Lv61
2040 积分 2021-02-23 加入
Aldosterone synthase inhibition in chronic kidney disease
12小时前
已完结
Rationale and design of the Women's Ischemia Trial to Reduce Events in Nonobstructive CAD (WARRIOR) trial
18天前
已完结
Effectiveness and safety of finerenone in non-diabetic patients with IgA nephropathy
28天前
已完结
Real-world use of finerenone in patients with chronic kidney disease and type 2 diabetes based on large-scale clinical studies: FIDELIO-DKD and FIGARO-DKD
29天前
已完结
The effects of empagliflozin on systemic haemodynamic function: three randomized, placebo-controlled trials
29天前
已完结
Cardiology: What You May Have Missed in 2024
1个月前
已完结
Endocrinology: What You May Have Missed in 2024
1个月前
已完结
Nephrology: What You May Have Missed in 2024
1个月前
已完结
Updates in chronic kidney disease management: A systematic review
1个月前
已完结
Role and application prospective of non-steroidal MRA in the treatment of diabetic kidney disease
1个月前
已完结
皖公网安备34019202002308
